BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 11773889)

  • 1. Are wound complications after a kidney transplant more common with modern immunosuppression?
    Humar A; Ramcharan T; Denny R; Gillingham KJ; Payne WD; Matas AJ
    Transplantation; 2001 Dec; 72(12):1920-3. PubMed ID: 11773889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of sirolimus, mycophenolate mofetil, cyclosporine, azathioprine, and steroids on wound healing in 513 kidney-transplant recipients.
    Flechner SM; Zhou L; Derweesh I; Mastroianni B; Savas K; Goldfarb D; Modlin CS; Krishnamurthi V; Novick A
    Transplantation; 2003 Dec; 76(12):1729-34. PubMed ID: 14688524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
    Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
    Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?
    Johnson DW; Nicol DL; Purdie DM; Preston JM; Brown AM; Hawley CM; Campbell SB; Wall D; Griffin AD; Isbel NM
    Transplantation; 2002 Apr; 73(7):1158-63. PubMed ID: 11965051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Infectious complications in using mofetil micofenolate in patients with renal allotransplant].
    Prokopenko EI; Shcherbakova EO; Vatazin AV; Kruglov EE; Pasov SA; Budnikova NE; Agafonova SG; Rusanova EV
    Ter Arkh; 2005; 77(1):67-72. PubMed ID: 15759459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound complications after primary and repeated midline, transverse and modified Makuuchi incision: A single-center experience in 696 patients.
    Hempel S; Kalauch A; Oehme F; Wolk S; Welsch T; Weitz J; Distler M
    Medicine (Baltimore); 2021 May; 100(20):e25989. PubMed ID: 34011091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of de novo everolimus-based immunosuppression on incisional complications in heart transplantation.
    Zuckermann A; Arizon JM; Dong G; Eisen HJ; Kobashigawa J; Lehmkuhl H; Ross H; Pelligrini C; Wang SS; Barten MJ
    Transplantation; 2011 Sep; 92(5):594-600. PubMed ID: 21862955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
    Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
    Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A; Le Meur Y; Ecotière L; Abou-Ayache R; Etienne I; Laurent C; Vuiblet V; Colosio C; Bouvier N; Aldigier JC; Rerolle JP; Javaugue V; Gand E; Bridoux F; Essig M; Hurault de Ligny B; Touchard G
    Transpl Int; 2016 Jan; 29(1):23-33. PubMed ID: 26729582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for wound healing complications in sirolimus-treated renal transplant recipients.
    Grim SA; Slover CM; Sankary H; Oberholzer J; Benedetti E; Clark NM
    Transplant Proc; 2006 Dec; 38(10):3520-3. PubMed ID: 17175320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical site complications in kidney transplant recipients: incidence, risk factors and outcomes in the modern era.
    Wong RBK; Minkovich M; Famure O; Li Y; Lee JY; Selzner M; Kim SJ; Ghanekar A
    Can J Surg; 2021; 64(6):E669-E676. PubMed ID: 34933944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study.
    Troppmann C; Pierce JL; Gandhi MM; Gallay BJ; McVicar JP; Perez RV
    Transplantation; 2003 Jul; 76(2):426-9. PubMed ID: 12883205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil vs azathioprine in a large population of elderly renal transplant patients.
    Meier-Kriesche HU; Morris JA; Chu AH; Steffen BJ; Gotz VP; Gordon RD; Kaplan B
    Nephrol Dial Transplant; 2004 Nov; 19(11):2864-9. PubMed ID: 15496562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does pretransplant obesity affect the outcome in kidney transplant recipients?
    Singh D; Lawen J; Alkhudair W
    Transplant Proc; 2005 Mar; 37(2):717-20. PubMed ID: 15848512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-renal transplant surgical complications with newer immunosuppressive drugs: mycophenolate mofetil vs. m-TOR inhibitors.
    Srivastava A; Muruganandham K; Vinodh PB; Singh P; Dubey D; Kapoor R; Kumar A; Sharma RK; Prasad N
    Int Urol Nephrol; 2010 Jun; 42(2):279-84. PubMed ID: 19557542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does mycophenolate mofetil increase the incidence of infections in renal transplant recipients?
    Prokopenko E; Scherbakova E; Vatazin A; Pasov S; Budnikova N; Agafonova S
    Drugs Exp Clin Res; 2005; 31(5-6):199-205. PubMed ID: 16425976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.